down arrow

MacroGenics, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5560991094
USD
1.38
-0.04 (-2.82%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Arcutis Biotherapeutics, Inc.
Arbutus Biopharma Corp.
ARS Pharmaceuticals, Inc.
Nurix Therapeutics, Inc.
MacroGenics, Inc.
Coherus BioSciences, Inc.
Oric Pharmaceuticals, Inc.
Icosavax, Inc.
KalVista Pharmaceuticals, Inc.
Erasca, Inc.
Cullinan Therapeutics, Inc.
Why is MacroGenics, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 16.27% and Operating profit at 9.01% over the last 5 years
2
The company has declared negative results in Mar'2025 after 2 consecutive positive quarters
  • NET SALES(Q) At USD 22.24 MM has Fallen at -42.25%
  • PRE-TAX PROFIT(Q) At USD -36.15 MM has Fallen at -163.51%
  • NET PROFIT(Q) At USD -36.25 MM has Fallen at -159.81%
3
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -55.93%, its profits have risen by 68%
4
Below par performance in long term as well as near term
  • Along with generating -55.93% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is MacroGenics, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
MacroGenics, Inc.
-59.88%
-0.78
87.24%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
16.27%
EBIT Growth (5y)
9.01%
EBIT to Interest (avg)
-128.79
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.88
Sales to Capital Employed (avg)
0.99
Tax Ratio
1.72%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.42
EV to EBIT
0.37
EV to EBITDA
0.40
EV to Capital Employed
0.52
EV to Sales
-0.24
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
142.78%
ROE (Latest)
-70.54%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
NET SALES(HY)

At USD 35.43 MM has Grown at 78.05%

NET PROFIT(9M)

Higher at USD -92.71 MM

-13What is not working for the Company
NET SALES(Q)

At USD 22.24 MM has Fallen at -42.25%

PRE-TAX PROFIT(Q)

At USD -36.15 MM has Fallen at -163.51%

NET PROFIT(Q)

At USD -36.25 MM has Fallen at -159.81%

RAW MATERIAL COST(Y)

Grown by 10.16% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 5.63 times

Here's what is not working for MacroGenics, Inc.
Net Sales
At USD 22.24 MM has Fallen at -42.25%
over average net sales of the previous four periods of USD 38.51 MM
MOJO Watch
Near term sales trend is extremely negative

Net Sales (USD MM)

Pre-Tax Profit
At USD -36.15 MM has Fallen at -163.51%
over average net sales of the previous four periods of USD -13.72 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -36.25 MM has Fallen at -159.81%
over average net sales of the previous four periods of USD -13.95 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Inventory Turnover Ratio
Lowest at 5.63 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Raw Material Cost
Grown by 10.16% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."